Related Experiment Video
Updated: Jan 7, 2026
07:09
The Sciatic Nerve Cuffing Model of Neuropathic Pain in Mice
Published on: July 16, 2014
49.2K
Glutaminergic Modulators as Potential Therapeutic Modalities for Neuropathic Pain.
Butchi Raju Akondi1, Siva Reddy Challa2, Ramya Bandarupalli3
1Department of Clinical Pharmacy and Pharmacology, Ibn Sina National College for Medical Studies, Jeddah, Saudi Arabia.
Acta Neurologica Taiwanica
|December 31, 2025
Summary
Neuropathic pain, caused by nerve damage, is difficult to treat. Emerging research highlights the glutaminergic system as a promising new target for developing effective pain medications.
Area of Science:
- Neuroscience
- Pharmacology
- Pain Management
Background:
- Chronic neuropathic pain affects millions, presenting a significant therapeutic challenge.
- Current pharmacotherapies, including NSAIDs and opiates, show limited efficacy.
- The underlying pathophysiological mechanisms of neuropathic pain are not fully understood.
Purpose of the Study:
- To review recent theoretical developments and experimental evidence for novel drug targets in neuropathic pain treatment.
- To focus on the glutaminergic system as a potential therapeutic target.
- To explore avenues for developing new pharmacotherapeutic strategies.
Main Methods:
- Review of theoretical frameworks and experimental data on neuropathic pain.
- Analysis of research focusing on the glutaminergic system.
- Examination of emerging drug targets and treatment strategies.
Main Results:
- The glutaminergic system has been identified as a novel and promising drug target for neuropathic pain.
- Recent research provides theoretical and experimental support for targeting this system.
- New classification schemes and international guidelines offer potential for individualized treatment.
Conclusions:
- Targeting the glutaminergic system holds significant potential for developing more effective neuropathic pain treatments.
- Further research and development of lead compounds are crucial for clinical translation.
- Advancements in understanding pathophysiological mechanisms can broaden therapeutic options for debilitating pain conditions.
Related Concept Videos
01:14Antiepileptic Drugs: Glutamate Antagonists
853
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
853
01:25Analgesia and Pain Management
1.4K
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
1.4K
01:30Ligand-Gated Ion Channel Receptor: Gating Mechanism
3.7K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
3.7K
01:19Ligand-gated Ion Channels
13.9K
Ligand-gated ion channels are transmembrane proteins with a channel for ions to pass through and a binding site for a ligand. The channel opens only when a ligand attaches to the binding site.
Three Subfamilies of Ligand-gated Ion Channels
Ligand-gated ion channels fall into three subfamilies. The 'Cys-loop' includes the nicotinic acetylcholine receptors, γ-aminobutyric acid (GABA), glycine, and 5-hydroxytryptamine receptors. The second one is the 'Pore-loop' channels that...
Three Subfamilies of Ligand-gated Ion Channels
Ligand-gated ion channels fall into three subfamilies. The 'Cys-loop' includes the nicotinic acetylcholine receptors, γ-aminobutyric acid (GABA), glycine, and 5-hydroxytryptamine receptors. The second one is the 'Pore-loop' channels that...
13.9K
01:29Spasmolytic Agents: Chemical Classification
1.3K
Spasmolytic agents are drugs used to alleviate muscle spasms and spasticity. They can be categorized into different chemical groups based on their mechanisms of action. Centrally acting spasmolytics primarily affect the spinal cord, while others directly target skeletal muscle cells.
A major class of centrally acting spasmolytics is the α2-agonist, such as tizanidine. These drugs bind to α2-adrenoceptors, inhibiting the release of the excitatory neurotransmitter glutamate. They also...
A major class of centrally acting spasmolytics is the α2-agonist, such as tizanidine. These drugs bind to α2-adrenoceptors, inhibiting the release of the excitatory neurotransmitter glutamate. They also...
1.3K
01:15Opioid Analgesics: Synthetic and Semisynthetic Opioids
875
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
875